CIMBA40 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Announcement Type: General Announcement
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE ASEAN 40 MALAYSIA
Stock Name: CIMBA40
Date Announced: 11/07/2012
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE ASEAN 40 Malaysia
Date: 11-Jul-2012
IOPV per unit (RM): 1.5690
Units in circulation (units): 8,100,000.00
Management Fee (% p.a.): 0.00
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.00
FTSE/ASEAN 40 Index: 10381.89
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE ASEAN 40 MALAYSIA
Stock Name: CIMBA40
Date Announced: 11/07/2012
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE ASEAN 40 Malaysia
Date: 11-Jul-2012
IOPV per unit (RM): 1.5690
Units in circulation (units): 8,100,000.00
Management Fee (% p.a.): 0.00
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.00
FTSE/ASEAN 40 Index: 10381.89
CIMBC25 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Announcement Type: General Announcement
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE CHINA 25
Stock Name: CIMBC25
Date Announced: 11/07/2012
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE China 25
Date: 11-Jul-2012
IOPV per unit (RM): 0.8284
Units in circulation (units): 13,650,000.00
Management Fee (% p.a.): 0.60
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.04
FTSE/Xinhua China 25 Index: 14408.06
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE CHINA 25
Stock Name: CIMBC25
Date Announced: 11/07/2012
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE China 25
Date: 11-Jul-2012
IOPV per unit (RM): 0.8284
Units in circulation (units): 13,650,000.00
Management Fee (% p.a.): 0.60
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.04
FTSE/Xinhua China 25 Index: 14408.06
TRINITY - OTHERS
Announcement Type: General Announcement
Company Name: TRINITY CORPORATION BERHAD
Stock Name: TRINITY
Date Announced: 11/07/2012
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: TRINITY CORPORATION BERHAD ("TRINITY" or "the Company")
(Formerly known as Talam Corporation Berhad)
PRESS STATEMENT ON THE DEBT SETTLEMENT WITH MENTERI BESAR SELANGOR (INCORPORATED)
Attachments: Press Statement-11July2012.pdf
Company Name: TRINITY CORPORATION BERHAD
Stock Name: TRINITY
Date Announced: 11/07/2012
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: TRINITY CORPORATION BERHAD ("TRINITY" or "the Company")
(Formerly known as Talam Corporation Berhad)
PRESS STATEMENT ON THE DEBT SETTLEMENT WITH MENTERI BESAR SELANGOR (INCORPORATED)
Attachments: Press Statement-11July2012.pdf
WCT - Listing Circular
Announcement Type: Listing Circular
Company Name: WCT BERHAD
Stock Name: WCT
Date Announced: 11/07/2012
Announcement Detail:
Subject: WCT-CONVERSION OF 44,000 IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES 2007/2012 OF RM0.10 EACH INTO 8,800 NEW ORDINARY SHARES OF RM0.50 EACH ("CONVERSION")
Contents: Kindly be advised that the abovementioned Company's additional 8,800 new ordinary shares of RM0.50 each arising from the aforesaid Conversion will be granted listing and quotation with effect from 9.00a.m., Thursday, 12 July 2012.
Company Name: WCT BERHAD
Stock Name: WCT
Date Announced: 11/07/2012
Announcement Detail:
Subject: WCT-CONVERSION OF 44,000 IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES 2007/2012 OF RM0.10 EACH INTO 8,800 NEW ORDINARY SHARES OF RM0.50 EACH ("CONVERSION")
Contents: Kindly be advised that the abovementioned Company's additional 8,800 new ordinary shares of RM0.50 each arising from the aforesaid Conversion will be granted listing and quotation with effect from 9.00a.m., Thursday, 12 July 2012.
No comments:
Post a Comment